Rockwell Medical, Inc. RMTI
8.09 USD +1.15 (+16.57%)
At closeNov 3, 2026, 4:10 PM EST
8.09 0.00 0.00%
After hours · Nov 3, 4:10 PM ET
7.45 Day range 8.24
4.89 52-week range 12.90
- YTD
- -2.53%
- 1 year
- -25.09%
News
seekingalpha.com Rockwell Medical, Inc. (RMTI) M&A Call Transcript Rockwell Medical, Inc. (RMTI) M&A Call Transcript
benzinga.com Rockwell Medical To Acquire Majority Of Vantive's Hemodialysis Business; Terms Not Disclosed Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc. (NASDAQ:RMTI) to…
prnewswire.com Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /PRNewswire/ -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today…
businesswire.com Rockwell Medical Announces Transformational Global Hemodialysis Acquisition WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is acquiring Vantive's HD concentrates, HD machines, water treatment systems, and related consumables and technical…
businesswire.com Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.
businesswire.com Rockwell Medical to Exhibit at ASN Kidney Week 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
businesswire.com Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to…
defenseworld.net Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC) Embecta (NASDAQ: EMBC - Get Free Report) and Rockwell Medical (NASDAQ: RMTI - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
benzinga.com HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $20 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $20 price target.
seekingalpha.com Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
zacks.com Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.
gurufocus.com Rockwell Medical Announces Second Quarter 2026 Results Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodial
benzinga.com Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.23) by 82.61 percent. This is a 300 percent decrease over losses of…
benzinga.com Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est Rockwell Medical (NASDAQ:RMTI) affirms FY2026 sales outlook from $70.000 million-$75.000 million to $70.000 million-$75.000 million vs $72.469 million estimate.
businesswire.com Rockwell Medical Announces Second Quarter 2026 Results WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive…
zacks.com Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com Rockwell Medical Advances Quality and Regulatory Leadership WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the…
benzinga.com Rockwell Medical Stock Keeps Nasdaq Listing After Compliance Notice Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…
businesswire.com Rockwell Medical Regains Compliance with Nasdaq Listing Requirements WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing…
businesswire.com Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026 WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $20 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and raises the price target from $2 to $20.
- benzinga.com Rockwell Medical Plans 1-for-10 Reverse Stock Split Next Week Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…
businesswire.com Rockwell Medical Announces 1-for-10 Reverse Stock Split WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.
benzinga.com What's Going On With Rockwell Medical Stock Wednesday? Rockwell Medical (RMTI) spikes 6.4% premarket. Discover key support and resistance levels as the stock tests its 20-day moving average.
benzinga.com Rockwell Medical Renews And Extends Its Product Purchase Agreement With aQua Dialysis The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will…
businesswire.com Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential…
gurufocus.com Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodia- benzinga.com Rockwell Medical Signs Three-Year Product Purchase Agreement With Heritage Dialysis Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…
businesswire.com Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and…
seekingalpha.com Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
zacks.com Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.04 per share a year ago.- benzinga.com Rockwell Medical Raises FY2026 Sales Guidance from $65.000M-$70.000M to $70.000M-$75.000M vs $73.769M Est Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual GuidanceNet Sales$70.0M to $75.0MGross Margin18% to 22%Adjusted EBITDA$1.0M to $2.0MOperating Cash FlowPositive
benzinga.com Rockwell Medical Q1 Adj. EPS $(0.01) Beats $(0.03) Estimate, Sales $17.336M Miss $17.954M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 50 percent. This is unchanged from the same period last year. The…- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $2.5 to $2.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Earnings Scheduled For March 26, 2026 - benzinga.com Rockwell Medical Sees FY2026 Sales $65.000M-$70.000M vs $75.153M Est GUIDANCEFor the third year in a row, Rockwell Medical's annual performance was directly in line with its annual guidance. In 2025, Rockwell Medical's achieved net sales, gross margin and Adjusted…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $2.5 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $2.5 price target.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Why Is Rockwell Medical Gaining Tuesday? Rockwell Medical (RMTI) stock rose after announcing preliminary Q4 and full-year 2025 financial results, with sales exceeding estimates.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Rockwell Medical Delivers Preliminary Full-Year 2025 Results Highlighting Year-Over-Year Revenue Growth To $69.5M, Improved Profitability, And $25M Cash Position Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial HighlightsThe Company expects net sales for the fourth quarter 2025 to be approximately $18.6 million. The Company expects net sales…
benzinga.com Rockwell Medical Adds 30 New Dialysis Customers in the Western US Amid Supply Disruptions Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2.5 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $3 to $2.5.
- benzinga.com Earnings Scheduled For November 12, 2025
- benzinga.com Rockwell Medical Affirms FY2025 Sales Guidance of $65.000M-$70.000M vs $68.374M Est Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $68.374 million estimate.
- benzinga.com Rockwell Medical Q3 Sales $15.927M Miss $16.241M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst consensus estimate of $16.241 million by 1.93 percent. This is a 43.75 percent decrease over sales…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket